AstraZeneca is investing $2.5bn in research and development and manufacturing in Beijing, as the drugmaker tries to move on after a scandal that led to the detention of a top executive in China.
阿斯利康正在北京投资25亿美元用于研发和制造，该制药公司正试图在一名高管因丑闻在manbetx3.0 被拘留后继续前进。
您已阅读7%（246字），剩余93%（3157字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。